Skip to main content
. Author manuscript; available in PMC: 2011 Jul 5.
Published in final edited form as: J Child Adolesc Psychopharmacol. 2006 Dec;16(6):755–765. doi: 10.1089/cap.2006.16.755

FIG. 1.

FIG. 1

Study timeline and titration schedule.

*Rivastigminc dose increased from 1.5 mg to 3.0 mg at week 2 (dose increase not associated with a study visit).